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Carotenoids are pigments found in fruits and vegetables. While high intakes of fruits and vegetables have been found to be associated with lower
mortality, our objective is to investigate if total plasma carotenoids, via their antioxidant properties, are associated with mortality risk in a free-
living elderly population. The ‘Epidemiology of Vascular Ageing’ (EVA) study (n 1389; 59–71 years) is a 9-year longitudinal study with six
waves of follow-up. The association between baseline total plasma carotenoids and mortality was determined by Cox proportional hazards
regression analyses. Low total plasma carotenoid level was signiﬁcantly associated with all-cause mortality in men but not in women. After con-
trolling for potential confounding factors, mortality risk increased signiﬁcantly in men (P¼0·03) with plasma carotenoids in the lowest quintile
compared with men with plasma carotenoids in the highest (relative risk 2·94 (95% CI 1·21, 7·17)). A signiﬁcant association between mortality
by cancer and low plasma carotenoid level variable was also found in men (unit ¼ 1mmol/l; relative risk 1·72 (95% CI 1·02, 2·86); P¼0·01).
Associations between total plasma carotenoids and mortality risk remained statistically signiﬁcant after taking into account: (1) plasma Se
level, which previously was found associated with mortality in this population and (2) thiobarbituric acid-reactive substances level considered
as an indicator of oxidative stress. By showing, prospectively, in a general healthy elderly population, that total plasma carotenoid levels were
independently associated with mortality risk in men, the present study suggests that total plasma carotenoid levels could be a health indicator
in elderly populations.
Total plasma carotenoids: Mortality: Elderly: Longitudinal studies
Carotenoids are natural pigments, synthesised by plants and
micro-organisms, but not by animals or humans. These pig-
ments are found in food, especially in fruits and vegetables.
Large epidemiological studies suggest a protective effect of a
high intake of fruits and vegetables on all-cause mortality
(1–5).
Consumption of fruits and vegetables could have a protective
effect on stroke and CHD
(6–10). Concerning cancer, the
beneﬁts of fruit and vegetable intake are more controversial
and the potential protective effect seems to depend on the
type of cancer. Some studies did not show evidence of a
strong association with ovarian cancer
(11), breast cancer
(12),
overall colon rectal cancer
(13,14) and renal cell carcinoma
(15).
However, some studies suggest potential beneﬁts of fruit and
vegetable consumption for some other cancers such as cancer
of the upper aero-digestive tract
(16) and lung cancer
(17,18).
More information is needed to ascertain the association
between the intake of single nutrients, such as carotenoids,
and the risk of all-cause mortality.
The hypothetical protective role of carotenoids could
come from their antioxidant properties
(19). Literature on the
implication of free radicals in the ageing process is well
documented
(20,21) but the relationship between total plasma
carotenoids and mortality in free-living elderly populations via
their antioxidant roles has not been previously studied. Other
underlying mechanisms such as inﬂammation mechanisms or
immunomodulatory mechanisms have also been mentioned
(19).
Our objective is to explore the relationships between total
plasma carotenoids at baseline and 9-year mortality risk in a
healthy elderly population.
Experimental methods
Study population
The ‘Epidemiology of Vascular Ageing’ (EVA) study is a
9-year longitudinal study with six follow-up periods
(22,23).
During the ﬁrst 2 years, 1991–1993 (EVA0), 1389 volunteers
(575 men and 814 women, age range 59–71 years) residing in
the town of Nantes (Western France) were recruited from elec-
toral rolls, and to a lesser extent, via information campaigns.
All subjects were community residents and underwent a com-
plete examination in the EVA study centre where they spent
*Corresponding author: Dr Tasnime Akbaraly, fax þ33 499614579, email t.akbaraly@ucl.ac.uk
Abbreviations: EVA, Epidemiology of Vascular Ageing; HR, hazard ratio; Q, quintile; TBARS, thiobarbituric acid-reactive substances.
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nhalf a day. The last follow-up of the EVA study (EVA6) was
conducted between June 2000 and December 2001. The study
protocol was approved by the Ethical Committee of the
University Centre Hospital of Kremlin-Bice ˆtre (Paris). Signed
informed consent was obtained from all participants at
enrolment.
Data collection
Vital statistics and date and cause of death were collected
throughout the 9 years of follow-up. At each of the EVA
steps, and at the end of the last year of study, the vital
status of individuals for whom we had no feedback was
collected from town hall civil registries. The cause of death
was determined with the help of both the subject’s general
practitioner and family.
At baseline, the general questionnaire allowed us to obtain
information on sociodemographic factors such as sex, age,
educational level (#primary school or $high school), plus
lifestyle habits such as smoking habit (current and ex-smokers
or non-smokers) and alcohol intake ($20ml or ,20ml per d).
In addition, height and weight were measured. Two indepen-
dent measures of systolic and diastolic blood pressure were
taken with a digital electronic tensiometer (SP9 Spengler)
after a 10min rest. Cognitive performances were assessed
using the Mini Mental Status Examination
(24). Blood samples
were collected between 08.30 and 09.30 hours after a 12h fast.
Total plasma cholesterol and plasma glucose levels were
measured using standard methods.
Health characteristics considered in this analysis were
Mini Mental Status Examination score, BMI, diabetes status
(plasma glucose level $7·80mmol/l, use of anti-diabetic
drugs or diabetes medical history), dyslipidaemia (total
cholesterol $6·20mmol/l, use of lipid-lowering drugs or dys-
lipidaemia medical history), hypertension (systolic or diastolic
blood pressure $140 or $90mmHg respectively, or use of
hypertensive drugs or hypertension medical history), history
of vascular diseases (self-reported history of myocardial
infarction, angina pectoris, stroke).
Laboratory procedures
Spectrophotometric assay of plasma carotenoids. After pre-
cipitation of plasma proteins with ethanol, carotenoids were
extracted with hexane and measurements of absorbance on
the hexane phase at 350, 450 and 550nm were performed
(spectrophotometer Uvikon 860; Kontron, Rotkreuz, Switzer-
land). Concentrations were calculated on the basis of a
molecular extinction factor at 450nm of 134000litres/mol
per cm. Absorbance values at 350 and 550nm were used to
correct the absorbance obtained at 450nm by applying an
adequate equation. Coefﬁcients of intra- and inter-assay
variations were 5·4 and 4·9%, respectively.
Thiobarbituricacid-reactivesubstancesandplasmaselenium
determination. Plasma levels of thiobarbituric acid-reactive
substances (TBARS) were determined by a ﬂuorometry
method as described by Richard et al.
(25) and described pre-
viously
(26). Se was determined in serum using electrothermal
atomic absorption spectrometry (Perkin Elmer 5100 ZT;
Norwalk,CT,USA)accordingtoArnaudetal.
(27)anddescribed
previously
(22).
Statistics
Survival was analysed with actuarial methods, and Wilcoxon
tests were used to compare survival between total plasma
carotenoid quintile groups. Associations between total
plasma carotenoids and mortality were determined by Cox
proportional hazards regression models in which year of age
during the study was used as the time axis, with left truncation
at the age of study entry. Multivariate analyses were adjusted
for potential confounding variables and similar analyses were
repeated after additionally taking into account TBARS levels
and plasma Se levels (analysed as continuous variables).
The proportional hazards assumption was veriﬁed by adding
a time-dependent variable to the model
(28). In these analyses,
total plasma carotenoid level was considered by quintiles
deﬁned in each sex and was also considered as a continuous
variable when the strength of analyses was too small to
allow a categorical treatment. Results of Cox multivariate
regressions were expressed by hazard ratios (HR) with their
95% CI. All interactions between total plasma carotenoids
and other variables were tested. Statistical analyses were
performed using SAS software version 9.1 (SAS Institute,
Inc., Cary, NC, USA).
Results
Of the 1389 study participants included in the analyses, 1283
had measurements of total plasma carotenoids and complete
information on covariables. Characteristics according to sex
are shown in Table 1. During the 9-year follow-up, ninety-
three deaths occurred, with a higher rate in men than
in women (sixty-one men, thirty-two women; P#10
24).
A higher mortality rate was observed in current and former
smokers, in regular alcohol consumers, in participants with
low concentration of plasma Se and with high BMI and
participants with diabetes, hypertension and CVD (results
not shown).
Total plasma carotenoid level was signiﬁcantly higher in
women (3·08 (SD 1·33) mmol/l) than in men (2·19 (SD 0·99)
mmol/l) (Table 1) and a discrepancy in the distribution was
observed between men and women (Fig. 1).
Means of total plasma carotenoids were signiﬁcantly higher
in surviving individuals (2·75 (SD 1·27) mmol/l) than in those
who died (2·12 (SD 1·12) mmol/l) (P,10
24). This association
was found to be sex-dependent. The relationship was found to
be signiﬁcant for men (2·24 (SD 0·97) v. 1·76 (SD 0·94) mmol/l;
P¼0·0002) but not for women (3·09 (SD 1·34) v. 2·83 (SD
1·11) mmol/l; P¼0·27). Comparison of survival distributions
among total plasma carotenoid quintiles shows that mortality
increased in subgroups with the lowest percentile groups of
total plasma carotenoids in men but not in women (Fig. 2).
The bivariate Cox proportional hazard regression (Table 2)
model showed that men in the lowest quintile (Q) of total
plasma carotenoids had a signiﬁcantly higher risk of
mortality than men in the highest (HRQ1v.Q5 4·08 (95% CI
1·77, 9·45)). No signiﬁcant association was found in men
who had a plasma carotenoid level within Q2, Q3 or Q4
compared with subjects in Q5 (Q2 v. Q5, HR 1·69 (95%
CI 0·65, 4·36); Q3 v. Q5, HR 1·07 (95% CI 0·38, 3·05);
Q4 v. Q5, HR 1·24 (95% CI 0·46, 3·34)). The global P
value in men was P¼0·0003. No signiﬁcant association
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CI 0·18, 2·11); Q2 v. Q5, HR 1·73 (95% CI 0·68, 4·39);
Q3 v. Q5, HR 0·59 (95% CI 0·17, 2·03); Q4 v. Q5, HR
0·74 (95% CI 0·23, 2·33)).
At baseline, a signiﬁcant association was observed between
concentration of plasma carotenoids and education level in
women (lower concentrations observed in women with low
education level) and marital status in men (higher concen-
trations in married men). In both sexes, a lower total plasma
carotenoid concentration was also observed in participants
who were regular alcohol consumers, in participants with
diabetes, hypertension, CVD history, and a higher concen-
tration was observed in dyslipidaemic participants. Plasma
carotenoid concentrations were also negatively correlated
with BMI and positively correlated with plasma Se in both
sexes and with TBARS levels in women.
The association between total plasma carotenoid levels and
9-year risk mortality was analysed after adjustment for all fac-
tors associated with mortality and/or with total plasma caro-
tenoids in each sex separately; results are presented in
Table 2. The multivariate Cox hazard proportions regression
models showed that low levels of plasma carotenoids were
associated with higher mortality risk in men but not in
women after controlling for age, education level, marital
status, smoking habits, alcohol intake and health factors (dia-
betes, hypertension, cardiovascular antecedents, dyslipidae-
mia, BMI). The HR of 9-year mortality in men with plasma
carotenoid levels in the lowest quintile compared with men
with plasma carotenoid levels in the highest quintile was
2·94 (95% CI 1·21, 7·17). No signiﬁcant association was
found for men who had a plasma carotenoid level within
Q2, Q3 or Q4 compared with subjects in Q5 (Q2 v. Q5, HR
1·33 (95% CI 0·50, 3·50); Q3 v. Q5, HR 0·98 (95% CI
0·34, 2·82); Q4 v. Q5, HR 1·22 (95% CI 0·45, 3·28)),
suggesting a threshold effect.
Similar analyses were performed after adjusting for
(1) TBARS levels, which could be considered as biological
markers of oxidative stress; (2) plasma Se level, which was
found to be associated with all-cause mortality in both
sexes. After these supplemental adjustments, total plasma
carotenoid levels still remained associated with 9-year mor-
tality risk in men: global P value¼0·04 after adjustment for
TBARS (Q1 v. Q5, HR 2·67 (95% CI 1·08, 6·61)) and
global P value¼0·04 after adjustment for plasma Se (Q1 v.
Q5, HR 2·52 (95% CI 1·03, 6·21)). Total plasma carotenoids
remained unrelated to mortality in women.
Table 1. Characteristics of 1283 participants included in the analyses according to sex
(Mean values and standard deviations)
Men (n 534) Women (n 749)
Mean SD Mean SD P
Sociodemographic and lifestyle habits
Age (years) 65·0 3·0 64·9 3·0 0·41
Education – primary school (%) 46·4 54·7 0·003
Marital status – not married (%) 6·5 30·2 ,0·0001
Smoking status – current or former smoker (%) 54·9 12·0 ,0·0001
Alcohol intake $ two glasses/d (%) 76·8 16·6 ,0·0001
Health factors
Diabetes (%) 9·2 2·5 ,0·0001
Hypertension (%) 57·5 44·7 ,0·0001
CVD history (%) 11·8 8·0 0·02
Dyslipidaemia (%) 61·8 77·6 ,0·0001
BMI (kg/m
2) 26·6 3·4 24·7 3·9 ,0·0001
MMSE score 28·2 2·1 27·9 2·3 0·004
Biological measurements
Plasma Se (mmol/l) 1·08 0·21 1·10 0·19 0·26
TBARS (mmol/l)* 0·46 0·06 0·47 0·06 0·002
Total plasma carotenoids (mmol/l) 2·19 0·99 3·08 1·33 ,0·0001
All-cause mortality over 9 years (%) 11·4 4·3 ,0·0001
MMSE, Mini Mental State Examination; TBARS, thiobarbituric acid-reactive substances.
*Measurements available for 484 men and 687 women.
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Fig. 1. Distribution of total plasma carotenoid levels in men (A) and
women ( ).
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practitioner for 88·1% of subjects. Cancer was the ﬁrst leading
cause of death (n 45; 44·5%). Men who died of cancer had a
signiﬁcantly lower total plasma carotenoid mean compared
with those in surviving individuals (2·34 (SD 0·97) v. 3·09
(SD 1·34) mmol/l; P¼0·0002). Results of Cox models
showed a signiﬁcant association between total plasma caroten-
oid level analysed as continuous variables and cancer mor-
tality risk in men (unit ¼ 1mmol/l; HR 1·85 (95% CI 1·14,
3·03); P¼0·01) but not in women (HR 1·07 (95% CI 0·75,
1·56); P¼0·67). After taking into account the sociodemo-
graphic, life habits and health variables, this association in
men remained signiﬁcant (HR 1·72 (95% CI 1·02, 2·86);
P¼0·04).
Discussion
The present study shows that low total plasma carotenoid level
was signiﬁcantly associated with all-cause mortality and mor-
tality by cancer, in men but not in women, after controlling for
the main potential confounding factors. We also highlighted
that this association was independent of plasma Se level,
which was found to be signiﬁcantly associated with all-
cause mortality in this population
(22).
The EVA study included a large number of volunteers,
whose educational status and cognitive function levels are
known to be linked with mortality risks, and this proportion
is higher in the EVA cohort than in the average French elderly
population. Despite this selection, total plasma carotenoid
concentrations were within the same ranges as those of differ-
ent European populations.
The lower total plasma carotenoid concentrations in men
compared with women in our cohort has been described in
several epidemiological studies
(29,30), especially for b-caro-
tene
(31,32). Regarding the large discrepancy in the distribution
of total plasma carotenoid concentration between the two
sexes, as the threshold of the lowest quintile in women
(,2·0mmol/l) was about the median in men, the lack of evi-
dence of association between total plasma carotenoid concen-
tration and mortality in women could be explained by the fact
that it is only participants with very low levels who have a
higher risk of mortality. Additionally, the higher number of
deaths observed in men than in women (61 v. 32) could also
participate to the lack of evidence of an association in
women. This difference of concentrations of plasma caroten-
oids between men and women could result from a higher
fruit and vegetable intake in women than in men explainable
by exogenous factors such as socio-cultural factors leading
to better dietary habits in women – a gender difference –
but we can not exclude the effect of endogenous factors in
the hormonal differences or lipid and nutrient transport differ-
ences
(33) – a sex difference. Anyway, the differences between
men and women for carotenoid distributions and mortality rate
led us to conclude that only stratiﬁed analyses on sex should
be undertaken to investigate and better understand relation-
ships between plasma carotenoid level and mortality risk.
Our ﬁnding was supported by results from the MacArthur
studies on Successful Aging
(34), in which low levels of
serum b-carotene (median value #0·17mmol/l) were signiﬁ-
cantly associated with 7-year all-cause mortality in men (OR
2·30 (95% CI 1·23, 4·31)) but not in women (OR 0·85
(95% CI 0·42, 1·75)). In the Women’s Health and Aging
studies (n 632; 70–79 years)
(35) a signiﬁcant link was found
in women between higher total serum carotenoids and a
lower risk of mortality (for 1 SD increase of log total caroten-
oids, relative risk 0·77 (95% CI 0·64, 0·84)). However, we
noted in this study that women’s geometric means of total
serum carotenoids were very low (mean 1·63mmol/l). In
non-stratiﬁed analyses, two other studies showed an associ-
ation between high levels of carotenoids compounds and
lower mortality risk. First, in the European study ‘Survey in
Europe on Nutrition and the Elderly, a Concerted Action’
(SENECA) (n 1168; 70–75 years)
(36), plasma carotene con-
centrations were signiﬁcantly associated with a lower mor-
tality risk (for an increment of 0·39mmol/l, relative risk 0·79
(95% CI 0·70, 0·89)). Second, in a study on 638 independently
living elderly subjects aged 65–85 years
(29), analyses of ter-
tiles of carotenoids showed a signiﬁcant link between all-
cause mortality and xanthophyll carotenoids, but not with
total serum carotenoids even if tests for trends were signiﬁcant
(P¼0·02). Discordance of the results according to the caroten-
oid compounds studied could come from the fact that all
carotenoid compounds have not the same biological proper-
ties. Finally, in another study led by Fletcher et al. on 1214
subjects (75–84 years)
(37), the relationship between plasma
b-carotene and all-cause mortality during the 4·4-year
follow-up did not remain statistically signiﬁcant after
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Fig. 2. (a) Survival distributions for each total plasma carotenoid quintile
group exclusively in men: quintile (Q) 1, ,1·36mmol/l (V); Q2, 1·36–
1·86mmol/l ( ); Q3, 1·86–2·3mmol/l (þ); Q4, 2·3–2·9mmol/l ( ); Q5,
$2·9mmol/l (O). (b) Survival distributions for each total plasma caro-
tenoid quintile group exclusively in women: Q1, ,2·0mmol/l (V); Q2,
2·0–2·60mmol/l ( ); Q3, 2·60–3·25mmol/l (þ); Q4, 3·25–4·04mmol/l ( );
Q5, $4·04mmol/l (O).
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nadjustment for potential confounding factors. The absence of a
signiﬁcant link could be explained by a sex effect, which was
not reported, or by the advanced age of the population or
more probably by relatively higher baseline levels of plasma
b-carotene in this population.
Concerning the randomised trials, two randomised con-
trolled trials led in the general population have investigated
the effects of supplementation on the incidence of cancer
and all-cause mortality
(33,38). In the Linxian trial conducted
on 29584 adult subjects
(38) a signiﬁcantly lower 5-year
total mortality risk occurred among those receiving sup-
plementation with b-carotene, vitamin E and Se. In the pri-
mary prevention trial SU.VI.MAX including 13017 French
adults
(33) a signiﬁcant protective effect of 7·5 years’ com-
bined antioxidant including b-carotene supplementation on
all-cause mortality was observed in men but not in
women. In this trial, the effect of supplementation was
also studied after stratiﬁcation on initial antioxidant plasma
levels. A net beneﬁt was observed only in men with a low
status of b-carotene or ascorbate but not in women
(39). How-
ever, in these combined multi-antioxidant supplementation
studies, it is impossible to isolate the proper effect of caro-
tenoids on mortality. However, the recent meta-analyses led
by Bjelakovic et al.
(40), carried out on sixty-eight rando-
mised trials with 232606 participants, showed that supple-
mentation of b-carotene singly or combined signiﬁcantly
increased mortality. One explanation could be that instead
of having a role in the pathogenesis of many chronic dis-
eases, oxidative stress may be a consequence of pathological
conditions. By eliminating free radicals from our organism,
we interfere with some essential defensive mechanisms
(40).
In this meta-analysis the authors did not take into account
sex as a covariable which could inﬂuence the intervention
effect across the trials and constitutes a limitation for inter-
preting their results.
When considering the underlying causes of death, we found
a signiﬁcant association between low total plasma carotenoids
and higher cancer mortality in men. The present results should
be viewed with some caution, given that only forty-ﬁve cancer
deaths occurred. While low intake or having a low serum con-
centration of b-carotene was suggested to be associated with
an elevated risk of cancer by epidemiological studies
(41) and
by one large randomised trial conducted in China, in the
early 1980s
(38), the results of recent trials recommend caution
concerning the potential beneﬁt of supplementation of caro-
tenes, by showing a higher rate of lung cancer in smoker par-
ticipants who received a supplement containing b-carotene
compared with those receiving placebo in the ATBC
Study
(42–44). Then, the association between carotenoids and
cancer seems to be speciﬁc to the cancer site. Our data did
not allow investigating associations between total plasma
carotenoids on speciﬁc cancer sites.
In a previous study, we showed a signiﬁcant association
between low plasma Se levels and all-cause mortality risk
and cancer mortality in both sexes
(22). In the present analyses,
after adjustment on plasma Se levels, associations between
total plasma carotenoids and mortality risk remained statisti-
cally signiﬁcant, suggesting that plasma Se and plasma
carotenoids have each of them a proper protective effect on
mortality risk. This result was supported by the Women’s
Health and Aging Studies results
(35).
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still under debate and, as it has been described by Paiva &
Russell, several hypotheses can explain this observation
(19).
One of them involves the antioxidant properties. In the present
study, analyses were repeated after controlling for TBARS
levels, a lipidoperoxidation marker; the present results
remained unchanged, suggesting that the association between
total plasma carotenoids and mortality observed in our
cohort did not arise from an antioxidant protection. However,
the oxidative stress marker role of TBARS seems controver-
sial and we have to remain cautious with such a conclusion
even if, in a placebo-controlled single-blind study, Hininger
et al. showed that carotenoid supplementation (lutein, lyco-
pene, b-carotene) did not lead to a signiﬁcantly measurable
improvement in antioxidant defence in apparently healthy
subjects (n 175; 25–45 years)
(45). The other underlying
mechanism by which low levels of carotenoids could contri-
bute to an increased risk of mortality may be related to inﬂam-
mation. In the MacArthur Studies of Successful Aging,
Hu et al. showed that serum b-carotene concentrations were
inversely associated with C-reactive protein and IL-6 levels,
and they showed an independent and synergic effect between
low b-carotene concentrations and high inﬂammation burden
on mortality risk
(34). Unfortunately, inﬂammation markers
were not available in the present study. Finally, two other
mechanisms have also been mentioned; on one hand, a poss-
ible pro-inﬂammatory and immunomodulatory mechanism is
hypothesised by the carotenoid’s activation of lipoxygenase
activities
(19). On the other hand, it has been suggested that
carotenoids may also be involved in the activation of gene
expression, which encodes the message for an element of
gap junction (connexin 43) required for cell-to-cell communi-
cation
(19). To our knowledge, neither the activity of lipoxy-
genases nor measurements of connexin 43 have ever been
taken into account in epidemiological studies interested in
the relationship between carotenoids and chronic diseases or
mortality in general populations. So, at this point, it seems
difﬁcult to be more precise on the mechanism by which caro-
tenoids could act. Finally, we cannot exclude that carotenoids
in the present study might have been serving as markers
for other protective factors present in fruits and vegetables,
but that are not acting as effective agents themselves. Further
biological research is necessary to conﬁrm the association
between carotenoids and mortality, particularly in elderly
subjects, to better understand the mechanism of action, and
so to be able to determine if the protective association of
carotenoids on mortality found in men but not in women is
only a random effect, a sex or a gender difference.
Byshowing,prospectively,inageneralhealthyelderly popu-
lation, that total plasma carotenoid levels were an independent
associated marker of mortality in men after taking into account
potential confounding factors, the present study suggests
that total plasma carotenoid levels could be a ‘healthy diet’
indicator in elderly populations. Further studies are necessary
to explore the mechanism which could explain the relationship.
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